Clinical Trials Logo
  1. Home
  2. Hyperlipidemias
  3. NCT04564352
  4. Details
NCT04564352 Clinical Trial

Hypolipidemic Effect of Adansonia Digitata

Hyperlipidemias Clinical Trial

— AD  

Official title:
Hypolipidemic, Antioxidant Activity of Adansonia Digitata Juice Consumption

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04564352
Other study ID # CLS 201978
Secondary ID Taibah Universit
Status Completed
Phase
First received
Last updated
Start date January 1, 2020
Est. completion date August 1, 2020

Study information
Verified date September 2020
Source Taibah University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Adansonia digitata L. (AD) also known as Baobab is a huge tree that grows in many countries in sub-Saharan Africa. Many studies talking about AD biological activity including hypolipidemic, antioxidant and antimicrobials in animal's but not in human, This study will be undertaken to examine the effect of AD juice consumption against lipid profiles in traditional users and blood samples will be collected form participant's for investigated of lipid profiles pre and post AD juice drinking and the results will be compared.

Recruitment information / eligibility
Status Completed
Enrollment 70
Est. completion date August 1, 2020
Est. primary completion date August 1, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Tradition users (drink AD juice)

Exclusion Criteria:

- Diabetes, hypertension, or chronic illness

Study Design

Related Conditions & MeSH terms

Intervention

Dietary Supplement:
• Adansonia digitata
Juice of AD fruit

Locations
Country Name City State
Saudi Arabia Taibah University Medina

Sponsors (1)
Lead Sponsor Collaborator
Taibah University

Country where clinical trial is conducted

Saudi Arabia, 

Outcome
Type Measure Description Time frame Safety issue
Primary Decrease cholesterol level Hypolipidemias 6 month's
See also
  Status Clinical Trial Phase
Completed NCT03793985 - Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337 Phase 1
Recruiting NCT03947866 - Ezetimibe-Rosuvastatin Evaluation Study
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Completed NCT04516291 - A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70) Phase 2
Completed NCT03632668 - Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072 Phase 1
Completed NCT04701775 - Effect of Different Probiotic Strains in Hypercholesterolemic Patients N/A
Completed NCT03534661 - L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release Phase 2/Phase 3
Completed NCT03422666 - Plasma Lipoprotein Response to Glucagon-like Peptide-2 Phase 2/Phase 3
Completed NCT00536796 - Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets N/A
Completed NCT03643705 - A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention N/A
Recruiting NCT04560296 - Community-based E-Health Program for Older Adults Living With Chronic Diseases N/A
Terminated NCT04073134 - The CHORAL Flow Study Phase 4
Recruiting NCT05103254 - Bempedoic Acid Pregnancy Surveillance Program
Not yet recruiting NCT05015348 - Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients With Hyperlipidemia N/A
Active, not recruiting NCT05082350 - Nutritional Intervention With Black Garlic N/A
Not yet recruiting NCT04398771 - To Evaluate Safety and Effectiveness of RovatitanTab.
Not yet recruiting NCT04064281 - The Healthy Cantonese Diet on Cardiometabolic Syndrome N/A
Recruiting NCT06257641 - Impact of the Mediterranean Diet on Patients With Psoriasis N/A
Completed NCT03690778 - The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers. Phase 1
Completed NCT04354987 - Compare the Pharmacokinetics and Safety of CKD-391 Phase 1